Corticosteroid therapy for primary treatment of Kawasaki disease - Weight of evidence: A meta-analysis and systematic review of the literature

Cardiovascular Journal of Africa

Volumn 20, Issue 4, 2009, Pages 233-236

  Athappan, Ganesh ^a   Gale, Seth ^a   Ponniah, Thirumalaikolundusubramanian ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; CLINICAL TRIAL; CORONARY ARTERY ANEURYSM; CORTICOSTEROID THERAPY; DISEASE COURSE; HUMAN; INCIDENCE; META ANALYSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETREATMENT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME;

ASPIRIN; COMBINED MODALITY THERAPY; CORONARY ANEURYSM; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 69949105260     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Curtis N. Kawasaki disease. Br Med J 1997; 315: 322-323.
2. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87: 1776-1780. (Pubitemid 23133135)
3. Taubert KA, Shulman ST. Kawasaki disease. Am Fam Phys 1999: 59. http://www.aafp.org/afp/990600ap/contents.html
4. Ariga S, Koga M, Takahashi M, Ishihara T, Matsubara T, Furukawa S. Maturation of macrophages from peripheral blood monocytes in Kawasaki disease: immunocytochemical and immunoelectron microscopic study. Pathol Int 2001; 51: 257-263. (Pubitemid 32472696)
5. Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979; 63: 175-179. (Pubitemid 9083134)
6. Newburger JW. Treatment of Kawasaki disease: corticosteroids revisited. J Pediatr 1999; 135: 411-413. (Pubitemid 30180466)
7. Kijima Y, Kamiya T, Suzuki A, Hirose O, Manabe H. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Jpn Circ J 1982; 46: 1239-1242. (Pubitemid 13183216)
8. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996; 128: 146-149. (Pubitemid 26028974)
9. Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 1999; 135: 465-469. (Pubitemid 30180475)
10. Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics 2005; 116: 989-995.
11. Inoue Y, Okada Y, Shinohara M, et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 2006; 149: 336-341. (Pubitemid 44308435)
12. Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, et al. Randomized trial of pulse corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 2007; 356(7): 663-675. (Pubitemid 46257229)
13. http://www.cochrane.org/resources/handbook/
14. http://www.cc-ims.net/RevMan
15. Higashi K, Terai M, Hamada H, Honda T, Kanazawa M, Kohno Y. Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease. Circ J 2007; 71(7): 1052-1059. (Pubitemid 46998019)
16. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001; 43(3): 211-217. (Pubitemid 32640933)
17. Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr 2003; 142(6): 611-616. (Pubitemid 36737160)
18. Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, Morikawa A, Gunma Kawasaki Disease Study Group. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 2003; 143(3): 363-367. (Pubitemid 37188322)
19. Barron KS. Kawasaki disease: etiology, pathogenesis and treatment. Cleve Clin J Med 2002; 69(Suppl 2): SII69-1178.
20. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-2771. (Pubitemid 39453026)